CD4-IgG binding threshold for inactivation of human immunodeficiency virus type 1

被引:5
作者
Berkower, I [1 ]
Mostowski, H [1 ]
Bull, TE [1 ]
Murphy, D [1 ]
机构
[1] NIH,BIOPHYS LAB,OFF VACCINE RES,CTR BIOL,FDA,BETHESDA,MD 20892
关键词
D O I
10.1093/infdis/173.4.863
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The stoichiometry of human immunodeficiency virus type 1 (HIV-1) inactivation by soluble receptor CD4-IgG hybrid dimers (CD4-IgG) was examined. The extent of HIV-1 inactivation was measured in a sensitive plaque-forming assay, and the corresponding level of CD4-IgG binding was determined by immunofluorescence of infected cells, Ninety percent virus inactivation occurred at relatively low levels of CD4-IgG binding (10% of the saturating level). At even lower binding levels (1.4% of maximum binding), virus survival was 44%. Over a broad range of binding conditions, the survival curve followed a model in which viruses binding more than a threshold level of CD4-IgG were completely inactivated, while viruses binding less remained infectious, The data indicate that CD4-IgG binding to 1.4% of gp120 binding sites equals the threshold for inactivation, Thus, virus inactivation can begin when 3 CD4-IgG (of similar to 216 gp120 sites) bind per virion.
引用
收藏
页码:863 / 869
页数:7
相关论文
共 34 条
  • [1] A PREDOMINANT GROUP-SPECIFIC NEUTRALIZING EPITOPE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MAPS TO RESIDUE-342 TO RESIDUE-511 OF THE ENVELOPE GLYCOPROTEIN-GP120
    BERKOWER, I
    MURPHY, D
    SMITH, CC
    SMITH, GE
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (11) : 5983 - 5990
  • [2] HUMAN IMMUNODEFICIENCY VIRUS-1 - PREDOMINANCE OF A GROUP-SPECIFIC NEUTRALIZING EPITOPE THAT PERSISTS DESPITE GENETIC-VARIATION
    BERKOWER, I
    SMITH, GE
    GIRI, C
    MURPHY, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (05) : 1681 - 1695
  • [3] DESIGNING CD4 IMMUNOADHESINS FOR AIDS THERAPY
    CAPON, DJ
    CHAMOW, SM
    MORDENTI, J
    MARSTERS, SA
    GREGORY, T
    MITSUYA, H
    BYRN, RA
    LUCAS, C
    WURM, FM
    GROOPMAN, JE
    BRODER, S
    SMITH, DH
    [J]. NATURE, 1989, 337 (6207) : 525 - 531
  • [4] SOLUBLE CD4 BLOCKS THE INFECTIVITY OF DIVERSE STRAINS OF HIV AND SIV FOR T-CELLS AND MONOCYTES BUT NOT FOR BRAIN AND MUSCLE-CELLS
    CLAPHAM, PR
    WEBER, JN
    WHITBY, D
    MCINTOSH, K
    DALGLEISH, AG
    MADDON, PJ
    DEEN, KC
    SWEET, RW
    WEISS, RA
    [J]. NATURE, 1989, 337 (6205) : 368 - 370
  • [5] COCHRAN MA, 1987, VACCINES 87 MODERN A, P384
  • [6] HIGH-CONCENTRATIONS OF RECOMBINANT SOLUBLE CD4 ARE REQUIRED TO NEUTRALIZE PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES
    DAAR, ES
    LI, XL
    MOUDGIL, T
    HO, DD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) : 6574 - 6578
  • [7] FUNCTIONAL BASIS OF POLIOVIRUS NEUTRALIZATION DETERMINED WITH MONOSPECIFIC NEUTRALIZING ANTIBODIES
    EMINI, EA
    KAO, SY
    LEWIS, AJ
    CRAINIC, R
    WIMMER, E
    [J]. JOURNAL OF VIROLOGY, 1983, 46 (02) : 466 - 474
  • [8] HIV INFECTION IS BLOCKED INVITRO BY RECOMBINANT SOLUBLE CD4
    FISHER, RA
    BERTONIS, JM
    MEIER, W
    JOHNSON, VA
    COSTOPOULOS, DS
    LIU, T
    TIZARD, R
    WALKER, BD
    HIRSCH, MS
    SCHOOLEY, RT
    FLAVELL, RA
    [J]. NATURE, 1988, 331 (6151) : 76 - 78
  • [9] DETECTION OF A FUSION PEPTIDE SEQUENCE IN THE TRANSMEMBRANE PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS
    GALLAHER, WR
    [J]. CELL, 1987, 50 (03) : 327 - 328
  • [10] ASSEMBLY AND MORPHOLOGY OF HIV - POTENTIAL EFFECT OF STRUCTURE ON VIRAL FUNCTION
    GELDERBLOM, HR
    [J]. AIDS, 1991, 5 (06) : 617 - 638